VARUBY

3 stories · following the connections

Business

TESARO Announces Approval of VARUBY® (Oral Rolapitant Tablets) by European Commission

By Nasdaq OMXApr 26, 2017, 12:31 PM UTC

Business

TESARO Announces Approval of VARUBY® (Oral Rolapitant Tablets) by European Commission

By Nasdaq OMXApr 26, 2017, 12:31 PM UTC

Business

TESARO Receives Positive CHMP Opinion for VARUBY®

By Nasdaq OMXFeb 27, 2017, 7:00 AM UTC